AstraZeneca PLC Ordinary Shares (AZN)

Capital Expenditure

-$5.07B

TTM · Period ending: · USD

AZN logo

AZN Capital Expenditure

Latest reported-$5.07B
AZN CapEx (-$540.10M → -$5.07B)
High-resolution chart · PNG

AZN capital expenditure history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Capital Expenditure — Annual fiscal periods (USD)
Period endingCapital Expenditure (USD)
-5,905,000,000
-4,586,000,000
-3,778,000,000
-2,571,000,000
-2,200,000,000
-2,606,000,000
-2,460,000,000
-1,371,000,000
-1,620,000,000
-2,314,000,000
-2,788,000,000
-2,752,000,000
-2,058,000,000
-4,619,000,000
-1,297,000,000
-2,420,000,000
-2,957,000,000
-4,039,000,000
-1,679,000,000
-1,339,000,000
-979,000,000
-332,000,000
-1,282,000,000
-1,340,000,000
-2,262,687,997
-1,460,747,999
-2,751,646,823
-844,883,393
-755,471,798
-638,764,257
-431,114,408
-492,472,210
-462,990,356
-406,473,238
-385,464,616
-540,102,619
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.